Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Farmers Insurance
Teva
Covington
McKesson
Colorcon
QuintilesIMS
Fish and Richardson
Accenture

Generated: April 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018498

« Back to Dashboard

NDA 018498 describes CYCLOCORT, which is a drug marketed by Astellas and is included in three NDAs. Additional details are available on the CYCLOCORT profile page.

The generic ingredient in CYCLOCORT is amcinonide. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the amcinonide profile page.
Summary for 018498
Tradename:CYCLOCORT
Applicant:Astellas
Ingredient:amcinonide
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:OINTMENT;TOPICALStrength0.1%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Teva
Healthtrust
Harvard Business School
US Army
Farmers Insurance
Colorcon
Federal Trade Commission
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.